Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Epilepsy

Free Subscription Articles published in Epilepsy Res Retrieve available abstracts of 238 articles: HTML format

Single Articles

October 2025
1. GONZALEZ-SALIDO J, Fuentes-Calvo I, Marin-Castaneda LA, Torres-Romero CM, et al
   EEG changes and seizure outcomes following anterior corpus callosotomy in adults with Lennox-Gastaut syndrome: A single-center experience.
   Epilepsy Res. 2025;216:107590.
   PubMed     Abstract available
   
   
   
2. GANDELMAN-MARTON R, Theitler J
   Post-pregnancy changes in seizure frequency and antiseizure medication treatment.
   Epilepsy Res. 2025;216:107595.
   PubMed     Abstract available
   
   
   
3. KYRGYZBAY G, Kalinina D, Akhmedullin R, Utebekov Z, et al
   Prevalence of migraine in individuals with functional seizures: A systematic review and meta-analysis.
   Epilepsy Res. 2025;216:107596.
   PubMed     Abstract available
   
   
   September 2025
4. DELL'ISOLA GB, Siciliano M, D'Onofrio G, Ferrara P, et al
   Ganaxolone in Epilepsy: Insights into a Neurosteroid-Based Therapy.
   Epilepsy Res. 2025;218:107669.
   PubMed     Abstract available
   
   
   
5. LIU H, Song Q, Jin J, Chen H, et al
   CREB3L4 upregulates SIRT4 expression to increase GABA/glutamate ratio and mitochondrial homeostasis for epilepsy suppression.
   Epilepsy Res. 2025;218:107668.
   PubMed     Abstract available
   
   
   
6. FATEH AA, Smahi A, Hassan M, Canete-Masse C, et al
   Dynamic functional connectivity variability in the thalamocortical circuit: Insights from Self-Limited Epilepsy with Centrotemporal Spikes (SeLECTs).
   Epilepsy Res. 2025;218:107665.
   PubMed     Abstract available
   
   
   
7. PUHAKKA N, Heiskanen M, Ndode-Ekane XE, Ali I, et al
   Standardization of preclinical methodologies for discovery and validation of circulating microRNA biomarkers for post-traumatic epileptogenesis - Lessons learned from the EpiBioS4Rx Project 1.
   Epilepsy Res. 2025;218:107667.
   PubMed     Abstract available
   
   
   
8. TAN X, Liu H, Li Y, Hu Q, et al
   Clinical and EEG characteristics of sleep-related hypermotor epilepsy in children.
   Epilepsy Res. 2025;218:107664.
   PubMed     Abstract available
   
   
   
9. KARAKIS I, Moura LM, Boualam N, Wetzel M, et al
   The health care costs of epilepsy: Evidence from all-payer claims data.
   Epilepsy Res. 2025;218:107661.
   PubMed     Abstract available
   
   
   
10. JAIN M, Charlesworth L, Driver H, Winston GP, et al
    Periodic limb movements among persons with epilepsy: A retrospective polysomnographic study.
    Epilepsy Res. 2025;218:107662.
    PubMed     Abstract available
    
    
    
11. HARO-PEREZ PS, Saltos-Ponce FA, Del Valle-Lascano CD, Cortes-Chiluiza RS, et al
    A comparison between magnetic resonance-guided laser interstitial thermal therapy and resective surgery for drug-resistant epilepsy in patients with MRI-positive focal cortical dysplasia: A systematic review and meta-analysis.
    Epilepsy Res. 2025;218:107660.
    PubMed     Abstract available
    
    
    
12. MUHE L, Kaufmann E, Landgraf MN, Tacke M, et al
    Influence of executive functions on quality of life in Pediatric Epilepsy: A cross-sectional study.
    Epilepsy Res. 2025;218:107646.
    PubMed     Abstract available
    
    
    
13. LIM ZD, Abdullah NAS, Lim KS, Ho PC, et al
    Exploring metabolic biomarkers and pathways in pharmacoresistant epilepsy: A systematic review.
    Epilepsy Res. 2025;218:107656.
    PubMed     Abstract available
    
    
    
14. BHAUMIK S, Nemichandra SC, Sharma D, Gopinath M, et al
    Real world observational study investigating clinical effectiveness and safety of lacosamide in epilepsy: ULTIMATE study.
    Epilepsy Res. 2025;218:107657.
    PubMed     Abstract available
    
    
    
15. KOZAA YA, Mohsen Y, Abuawwad MT, Rakab MS, et al
    Addressing the gap: SUDEP knowledge and communication among patients and neurologists.
    Epilepsy Res. 2025;215:107584.
    PubMed     Abstract available
    
    
    August 2025
16. DANIELE K, Raudenska J, Javurkova A
    Attention-deficit/hyperactivity disorder in adults with epilepsy: Preliminary prevalence and associated factors in a Czech sample.
    Epilepsy Res. 2025;218:107645.
    PubMed     Abstract available
    
    
    
17. RHODES C, Rees B, Dubbs H, Lesser M, et al
    Natural history of epilepsy in FOXG1 Syndrome.
    Epilepsy Res. 2025;218:107644.
    PubMed     Abstract available
    
    
    
18. VASILICA AM, Dhaliwal JK, Dasgupta D, Chari A, et al
    Outcomes of surgically and non-surgically managed temporal encephalocoeles in the context of drug-resistant temporal lobe epilepsy: A retrospective single-centre case series.
    Epilepsy Res. 2025;218:107643.
    PubMed     Abstract available
    
    
    
19. DEGASPERIS S, RamachandranNair R, Jones KC, Whitney R, et al
    SYNGAP-1 developmental and epileptic encephalopathy: Utility of corpus callosotomy and neuromodulation.
    Epilepsy Res. 2025;218:107641.
    PubMed     Abstract available
    
    
    
20. PEEPLES H, Achter E, Dieyi C, Maughn K, et al
    Health care burden of access barriers to epilepsy care in the United States: A claims-based analysis of payer channels.
    Epilepsy Res. 2025;218:107639.
    PubMed     Abstract available
    
    
    
21. GAO Y, Li X, Yong Z, Yuan B, et al
    Analysis of risk factors for recurrence after the withdrawal of ASMs in 135 children with epilepsy.
    Epilepsy Res. 2025;218:107638.
    PubMed     Abstract available
    
    
    
22. EBONG I, Eads P, Charles G
    Perceptions of health disparities among neurologists treating Black patients with epilepsy: A survey study in the United States.
    Epilepsy Res. 2025;218:107637.
    PubMed     Abstract available
    
    
    
23. STILLMAN C, Knupp K, Oliver J, Conley A, et al
    A retrospective analysis of pediatric patients on a ketogenic diet: A comparison of inpatient versus outpatient diet initiations.
    Epilepsy Res. 2025;214:107556.
    PubMed     Abstract available
    
    
    
24. HARFORD EE, Mandava A, Dede O, Sinha A, et al
    Long-term musculoskeletal outcomes in pediatric hemispherotomy.
    Epilepsy Res. 2025;214:107560.
    PubMed     Abstract available
    
    
    July 2025
25. SAKOVICS A, Csukly G, Borbely C, Kelemen A, et al
    Interictal epileptiform discharges as the most significant confounding factor underlying memory impairment in focal epilepsy.
    Epilepsy Res. 2025;218:107636.
    PubMed     Abstract available
    
    
    
26. PRADHAN N, Kumar M, Sandhya M, Bairwa P, et al
    Investigation of in-vivo GABA(+) and Glutamate levels in patients with drug resistant unilateral temporal lobe epilepsy using MEGA-PRESS and correlates with clinical semiology.
    Epilepsy Res. 2025;218:107625.
    PubMed     Abstract available
    
    
    
27. SHARAWAT IK, Kasinathan A, Panda P, Dawman L, et al
    Efficacy and tolerability of magnesium sulfate in children with infantile epileptic spasms syndrome: A systematic review and meta-analysis.
    Epilepsy Res. 2025;217:107628.
    PubMed     Abstract available
    
    
    
28. HAN Y, Gong S, Sun S, Yang D, et al
    Depressive symptoms in Chinese patients with epilepsy: Prevalence and clinical correlates.
    Epilepsy Res. 2025;217:107624.
    PubMed     Abstract available
    
    
    
29. KIM HJ, Kim MJ, Kim EA, Kwon O, et al
    Childhood-onset epilepsy: Longitudinal seizure outcomes in a large single-center cohort.
    Epilepsy Res. 2025;217:107622.
    PubMed     Abstract available
    
    
    
30. PEREIRA DA SILVA AM, Ohannesian VA, Falcao L, Ribeiro FV, et al
    Machine learning models for predicting therapeutic response in drug-resistant epilepsy: A bivariate diagnostic meta-analysis.
    Epilepsy Res. 2025;217:107623.
    PubMed     Abstract available
    
    
    
31. MOU L, Zhang Y, Liu C, Zhang MM, et al
    Evaluation and clinical characteristics of anxiety, depression, and sleep quality among adult patients with seizure clusters.
    Epilepsy Res. 2025;213:107552.
    PubMed     Abstract available
    
    
    
32. MEISE E, Bertsche T, Jeschke S, Bertsche A, et al
    Treatment modifications of antiseizure medications in children due to adverse drug reactions: The parents' perspective.
    Epilepsy Res. 2025;213:107548.
    PubMed     Abstract available
    
    
    
33. ZHAN C, Wang Q, Wang W, Lu X, et al
    Theta functional connectivity alterations related to executive control in refractory temporal lobe epilepsy.
    Epilepsy Res. 2025;217:107620.
    PubMed     Abstract available
    
    
    
34. SHAHAR E, Attias U, Savulescu D, Genizin J, et al
    Corrigendum to "Oxidative stress, metalloproteinase and LDH in children with intractable and non-intractable epilepsy as reflected in salivary analysis" [Epilepsy Res. 108 (1) (2014) 117-124].
    Epilepsy Res. 2025 Jul 1:107612. doi: 10.1016/j.eplepsyres.2025.107612.
    PubMed    
    
    
    
35. STONE A, Burre J, Wayland N, Grinspan ZM, et al
    Phenylbutyrate for monogenetic epilepsy: Literature review.
    Epilepsy Res. 2025;217:107621.
    PubMed     Abstract available
    
    
    June 2025
36. MAIO S, Fernandes M, Placidi F, Izzi F, et al
    Blood-brain barrier impairment as an early marker of neurodegeneration in late-onset epilepsy of unknown origin.
    Epilepsy Res. 2025;217:107614.
    PubMed     Abstract available
    
    
    
37. COUPER RG, Antaya TC, Carter B, Shariff SZ, et al
    Association between statin use and post-ischemic stroke epilepsy among older adults: A nested case-control study.
    Epilepsy Res. 2025;217:107617.
    PubMed     Abstract available
    
    
    
38. KHADIJA A, Theitler J, Gandelman-Marton R
    Seizure outcome and anti-seizure medication use in post-stroke epilepsy: A retrospective cohort study.
    Epilepsy Res. 2025;217:107616.
    PubMed     Abstract available
    
    
    
39. CORRIGAN D, Doherty CP, Jacquemard T, Delanty N, et al
    Turning data analytics into an organisational asset: A landscape population analysis of 5720 people with epilepsy attending outpatient care in Ireland.
    Epilepsy Res. 2025;217:107613.
    PubMed     Abstract available
    
    
    
40. SAWAMURA F, Natsume J, Ito Y, Mitsumatsu T, et al
    Latent renal tubular dysfunction in patients with epilepsy treated with valproic acid.
    Epilepsy Res. 2025;216:107611.
    PubMed     Abstract available
    
    
    
41. DHALIWAL JK, Ruiz-Perez M, Chari A, Piper RJ, et al
    Deep brain stimulation for epilepsy: A systematic review and meta-analysis of randomized and non-randomized studies of thalamic targeting.
    Epilepsy Res. 2025;216:107607.
    PubMed     Abstract available
    
    
    
42. WASEEM MH, Abideen ZU, Hussain F, Jamil Z, et al
    Demographic and regional trends in status epilepticus-related mortality among older adults in the United States (1999-2020): A nationwide retrospective analysis.
    Epilepsy Res. 2025;216:107610.
    PubMed     Abstract available
    
    
    
43. YU Q, Jiang SX, Lan MJ, Xu ZY, et al
    Surgical satisfaction and influencing factors in patients with epilepsy in China.
    Epilepsy Res. 2025;216:107608.
    PubMed     Abstract available
    
    
    May 2025
44. ASLAN O, Karasekreter N, Balim C, Yaman S, et al
    Classification of epilepsy seizure types in pediatrics based on Turkish EEG reports.
    Epilepsy Res. 2025;215:107593.
    PubMed     Abstract available
    
    
    
45. ALIYIANIS TS, Winston GP
    The impact of cognitive impairment due to epilepsy on quality of life: What do we know?
    Epilepsy Res. 2025;215:107592.
    PubMed     Abstract available
    
    
    
46. ZHOU R, Sullivan-Baca E, Bart T, Pugh MJ, et al
    Social determinants of health and healthcare utilization in veterans with post-traumatic epilepsy.
    Epilepsy Res. 2025;216:107594.
    PubMed     Abstract available
    
    
    
47. MOURA L, Karakis I, Howard D
    Corrigendum to "Emergency department utilization among adults with epilepsy: A multi-state cross-sectional analysis, 2010-2019" [Epilepsy Res. 205 (2024) 107427].
    Epilepsy Res. 2025 May 20:107588. doi: 10.1016/j.eplepsyres.2025.107588.
    PubMed    
    
    
    
48. LIU N, Lin Z, Song H, Cai A, et al
    Functional evaluation of a rat model of KCNT1-related epilepsy.
    Epilepsy Res. 2025;216:107589.
    PubMed     Abstract available
    
    
    
49. ZENDEHBAD SA, Razavi AS, Tabrizi N, Sedaghat Z, et al
    A systematic review of artificial intelligence techniques based on electroencephalography analysis in the diagnosis of epilepsy disorders: A clinical perspective.
    Epilepsy Res. 2025;215:107582.
    PubMed     Abstract available
    
    
    
50. LI H, Zhang P, Dong X, Wang Y, et al
    Efficacy and safety of perampanel in genetic generalized epilepsy: A retrospective, single-center study in China.
    Epilepsy Res. 2025;215:107591.
    PubMed     Abstract available
    
    
    
51. LI R, Geng R, Xu X, Wang C, et al
    Clinical efficacy of lacosamide monotherapy in children with focal epilepsy and comorbid depression and its impact on peripheral blood interleukin-6 and serotonin expression.
    Epilepsy Res. 2025;216:107587.
    PubMed     Abstract available
    
    
    
52. SARAC E, Yildiz E
    The construct validity of perceived disability scale in people with epilepsy.
    Epilepsy Res. 2025;215:107585.
    PubMed     Abstract available
    
    
    
53. NEPAL G, Yadav JK, Lamsal S, Ojha R, et al
    Pragmatic strategies for improving prevention, diagnosis, and treatment of epilepsy in low- and middle-income countries.
    Epilepsy Res. 2025;215:107586.
    PubMed     Abstract available
    
    
    
54. MAKKAWI S, Alsamiri GY, Halabi MH, Bukhari JI, et al
    Efficacy of transcutaneous vagus nerve stimulation (t-VNS) in treating drug-resistant epilepsy: A systematic review and meta-analysis.
    Epilepsy Res. 2025;215:107583.
    PubMed     Abstract available
    
    
    
55. HAQ UU, Majeed N, Kumari N, Saleh A, et al
    Phenobarbital versus valproate for generalized convulsive status epilepticus in adults. An updated systematic review and meta-analysis.
    Epilepsy Res. 2025;215:107571.
    PubMed     Abstract available
    
    
    
56. ZHUANG J, Fei L, Li H, Li K, et al
    Anatomical-electroclinical phenotypes and SEEG-defined network patterns in pure insular lobe epilepsy: A study of 20 cases.
    Epilepsy Res. 2025;215:107558.
    PubMed     Abstract available
    
    
    April 2025
57. SCHRADER S, Smith M
    Adequate and inadequate dosing of anti-seizure medications in status epilepticus.
    Epilepsy Res. 2025;214:107569.
    PubMed     Abstract available
    
    
    
58. GAIDIN SG, Maiorov SA, Zinchenko VP, Laryushkin DP, et al
    Pharmacological inhibition of PLC and PKC triggers epileptiform activity in hippocampal neurons.
    Epilepsy Res. 2025;214:107570.
    PubMed     Abstract available
    
    
    
59. HANEEF Z, Eisenschenk S, Lopez MR, Hildebrand A, et al
    Optimizing drug-resistant epilepsy identification in the Veterans Health Administration.
    Epilepsy Res. 2025;214:107568.
    PubMed     Abstract available
    
    
    
60. MARTIMBIANCO ALC, Silva RB, Cruz Latorraca CO, de Toledo IP, et al
    Cannabis derivatives and their synthetic analogs for treatment-resistant epilepsy: A systematic review and meta-analysis.
    Epilepsy Res. 2025;214:107559.
    PubMed     Abstract available
    
    
    
61. SURESH S, Modiano Y, Chaitanya G, Vashin V, et al
    Seizure and cognitive outcomes of cortical long bursting responsive neurostimulation in intractable focal epilepsy.
    Epilepsy Res. 2025;214:107555.
    PubMed     Abstract available
    
    
    
62. HANSEN NS, Ohman I, Ekstrom L, Petrenaite V, et al
    UGT polymorphisms and epileptic seizure control in pregnant women treated with Lamotrigine.
    Epilepsy Res. 2025;213:107554.
    PubMed     Abstract available
    
    
    
63. SMEARMAN J, Cunningham B, Fowler M, Nwachuku E, et al
    Associating clinical outcomes and number of antiseizure medications in refractory status epilepticus.
    Epilepsy Res. 2025;213:107547.
    PubMed     Abstract available
    
    
    
64. KESKIN-GULER S, Karadas O, Atmaca MM, Ozek SU, et al
    Enteral topiramate treatment in refractory status epilepticus.
    Epilepsy Res. 2025;213:107551.
    PubMed     Abstract available
    
    
    
65. SINGH T, Mehra A, Batabyal T, Joshi S, et al
    Thrombin mediates seizures following cortical injury-induced status epilepticus.
    Epilepsy Res. 2025;213:107549.
    PubMed     Abstract available
    
    
    
66. DILER DURGUT B, Dilber B, Kamasak T, Yaman H, et al
    The relationship between ghrelin, epilepsy-related inflammatory biomarkers (IL-1beta, IL-1R1, HMGB1), and drug-resistant epilepsy in children.
    Epilepsy Res. 2025;213:107553.
    PubMed     Abstract available
    
    
    
67. WANIGASINGHE J, Arambepola C, de Silva PA, Abeygunaratne D, et al
    Impact of the economic crisis in Sri Lanka on health and healthcare related to epilepsy.
    Epilepsy Res. 2025;214:107550.
    PubMed     Abstract available
    
    
    March 2025
68. OCTAVIANA F, Harsono AR, Wiratman W, Indrawati LA, et al
    Use of oral anti-seizure medication via nasogastric tube to treat IV-diazepam resistant status epilepticus in a setting with limited resources: An observational study.
    Epilepsy Res. 2025;212:107544.
    PubMed     Abstract available
    
    
    February 2025
69. OZDEMIR O, Tuglu F
    Personal impact of epilepsy and well-being in individuals with epilepsy.
    Epilepsy Res. 2025;212:107536.
    PubMed     Abstract available
    
    
    
70. NGUYEN DD, Tran TKA, Tran TPY, Pham QNB, et al
    The role of seizure video recordings in the diagnosis of referred drug-resistant epilepsy: A stepwise approach.
    Epilepsy Res. 2025;211:107530.
    PubMed     Abstract available
    
    
    
71. KOLP H, Hackert JK, Heerdegen M, Unger C, et al
    Extracellular bromide enhances GABA(A) receptor function in the immature, but not the adolescent rat pilocarpine epilepsy model.
    Epilepsy Res. 2025;211:107535.
    PubMed     Abstract available
    
    
    
72. GOLDENHOLZ DM, Goldenholz SR, Habib S, Westover MB, et al
    Inductive reasoning with large language models: A simulated randomized controlled trial for epilepsy.
    Epilepsy Res. 2025;211:107532.
    PubMed     Abstract available
    
    
    
73. PANDA PK, Sharawat IK
    Psychogenic non-epileptic seizures and epilepsy: How are they affected by associated psychiatric disorders?
    Epilepsy Res. 2025;211:107534.
    PubMed    
    
    
    
74. KISHK NA, Fouad AM, El-Sawy S, Soliman NA, et al
    Impact of valproate therapy on timing of puberty in adolescents with childhood-onset epilepsy.
    Epilepsy Res. 2025;211:107533.
    PubMed     Abstract available
    
    
    
75. LEE SY, Lee H, Cho JW, Kang KW, et al
    Corrigendum to "Long-term outcome and predictors of vagus nerve stimulation for drug-resistant epilepsy: Real-world evidence from the Korean National Hospital Consortium" [Epilepsy Res. 210 (2025) 107511 0920-1211].
    Epilepsy Res. 2025 Feb 17:107522. doi: 10.1016/j.eplepsyres.2025.107522.
    PubMed    
    
    
    
76. HAN Z, Xie L, Liu X, Yang J, et al
    Characterization of the phenotype and functional alternations of three HCN1 variants in Chinese epilepsy patients.
    Epilepsy Res. 2025;211:107521.
    PubMed     Abstract available
    
    
    
77. AGGARWAL Y, Dixit AB, Tripathi M, Doddamani R, et al
    Action potential-dependent alpha4-containing GABA(A) receptors contribute to epileptogenicity in focal cortical dysplasia.
    Epilepsy Res. 2025;210:107520.
    PubMed     Abstract available
    
    
    
78. MUNIYANDI M, Chelvanayagam K, Salam SA, Vadamalai S, et al
    Corrigendum to "Significant reduction of seizure frequency in patients with drug-resistant epilepsy by vagus nerve stimulation: Systematic review and meta-analysis" [Epilepsy Res. 210 (2025) 107510].
    Epilepsy Res. 2025 Feb 1:107519. doi: 10.1016/j.eplepsyres.2025.107519.
    PubMed    
    
    
    
79. DELEEUW MB, Shen W, Tian X, Ding C, et al
    4-Phenylbutyrate restored GABA uptake, mitigated seizures in SLC6A1 and SLC6A11 microdeletions/3p- syndrome: From cellular models to human patients.
    Epilepsy Res. 2025;210:107514.
    PubMed     Abstract available
    
    
    
80. KOWALSKI CE, Brown WS, Nolty AAT, Panos A, et al
    Daily executive functioning in adults with pediatric hemispherectomy.
    Epilepsy Res. 2025;210:107509.
    PubMed     Abstract available
    
    
    
81. YAMAMOTO T, Lim SC, Ninomiya H, Kubota Y, et al
    Long-term efficacy and safety of perampanel monotherapy in patients with newly diagnosed or currently untreated recurrent focal-onset seizures: Results from the open-label extension phase of FREEDOM (Study 342).
    Epilepsy Res. 2025;210:107494.
    PubMed     Abstract available
    
    
    January 2025
82. SURYAWANSHI VR, Srivastava K, Raut A, Sarangi B, et al
    Tenets of timing: An evidence based comprehensive review on time-lag in the management of pediatric status epilepticus and its effect on clinical outcomes.
    Epilepsy Res. 2025;210:107518.
    PubMed     Abstract available
    
    
    
83. SINGH S, Mithani K, Ochi A, Otsubo H, et al
    SEEG guided mapping of primary motor cortex in children with epilepsy.
    Epilepsy Res. 2025;210:107517.
    PubMed     Abstract available
    
    
    
84. SPEAKES ME, Reznik-Schaefer K, Al-Ramadhani R, Fernandez LD, et al
    Treatment of pediatric drug-resistant generalized epilepsy with responsive neurostimulation of the centromedian nucleus of the thalamus: A case series of seven patients.
    Epilepsy Res. 2025;210:107516.
    PubMed     Abstract available
    
    
    
85. LEE SY, Lee H, Cho JW, Kang KW, et al
    Long-term outcome and predictors of vagus nerve stimulation for drug-resistant epilepsy: Real-world evidence from the Korean national hospital consortium.
    Epilepsy Res. 2025;210:107511.
    PubMed     Abstract available
    
    
    
86. CHEN Y, Yang SN, Fu GL, Liu XX, et al
    Effects of MeCP2 on chronic seizures and cognitive function in mice with temporal lobe epilepsy.
    Epilepsy Res. 2025;210:107512.
    PubMed     Abstract available
    
    
    
87. MUNIYANDI M, Chelvanayagam K, Salam SA, Vadamalai S, et al
    Significant reduction of seizure frequency in patients with drug-resistant epilepsy by vagus nerve stimulation: Systematic review and meta-analysis.
    Epilepsy Res. 2025;210:107510.
    PubMed     Abstract available
    
    
    
88. POYTAKANGAS T, Basnyat P, Rainesalo S, Peltola J, et al
    Use of benzodiazepines in patients with status epilepticus requiring second-line antiseizure medication treatment.
    Epilepsy Res. 2025;210:107507.
    PubMed     Abstract available
    
    
    
89. CHEN H, Ju L, Ji Y, Tao L, et al
    The significance of interictal electroencephalogram analysis based on the grand total electroencephalogram score in early assessment of cognitive impairment in epilepsy patients.
    Epilepsy Res. 2025;210:107506.
    PubMed     Abstract available
    
    
    
90. SAMANTA D, Aungaroon G, Fine AL, Karakas C, et al
    Neuromodulation Strategies in Lennox-Gastaut Syndrome: Practical Clinical Guidance from the Pediatric Epilepsy Research Consortium.
    Epilepsy Res. 2025;210:107499.
    PubMed     Abstract available
    
    
    
91. SAOUDA C, Nofal O, Makke Y, Eid A, et al
    Effectiveness and tolerability of cenobamate: A single center experience.
    Epilepsy Res. 2025;209:107498.
    PubMed     Abstract available
    
    
    
92. BOURIKAS D, Koch J, de la Loge C, Dimova S, et al
    Long-term efficacy and tolerability of brivaracetam in pediatric patients with focal-onset seizures and cognitive or learning comorbidities: Post hoc analysis of an open-label trial.
    Epilepsy Res. 2025;209:107482.
    PubMed     Abstract available
    
    
    December 2024
93. HOSNY HS, Adly MS, Abdo SS, Khalil S, et al
    Late onset epilepsy findings in a developmental country, a report of first results.
    Epilepsy Res. 2024;209:107496.
    PubMed     Abstract available
    
    
    
94. MEKKAWY DA, Kishk N, Abokrysha NT, Ramzy GM, et al
    Epilepsy Arabic renaming to cerebroelectric disorder could minimize the stigma.
    Epilepsy Res. 2024;210:107495.
    PubMed     Abstract available
    
    
    
95. COLIJN MA
    The characterization of psychosis and response to antipsychotic therapy in monogenic forms of familial focal epilepsy: A systematic review.
    Epilepsy Res. 2024;209:107493.
    PubMed     Abstract available
    
    
    
96. SOTIROPOULOU N, Kinney M, Olaniyan T, Salako K, et al
    An advocacy based cross sectional study of healthcare professionals of factors impacting on medication adherence across nine Sub-Saharan African countries.
    Epilepsy Res. 2024;208:107459.
    PubMed     Abstract available
    
    
    
97. TRUDGEN MT, McKaig BR, Jain R, Kerr WT, et al
    Differential electrographic seizure patterns in malformations of cortical development, early life brain injury, and later life brain injury.
    Epilepsy Res. 2024;208:107470.
    PubMed     Abstract available
    
    
    November 2024
98. MITCHELL JW, Batchelor R, Adan G, Noble A, et al
    Epilepsy core outcome set for effectiveness trials (EPSET): A systematic review of outcomes measured in registered phase III and IV clinical trials for adults with epilepsy.
    Epilepsy Res. 2024;209:107481.
    PubMed     Abstract available
    
    
    
99. SAITO Y, Sugai K, Iwasaki M, Sato N, et al
    Surgical outcome and contributing presurgical evaluations in children with magnetic resonance imaging-negative epilepsy and periodic seizure cycles.
    Epilepsy Res. 2024;209:107492.
    PubMed     Abstract available
    
    
    
100. SHUKLA G, Sablok R, Shivji Z, Fogel S, et al
     Cannabis use, sleep and mood disturbances among persons with epilepsy - A clinical and polysomnography study from a Canadian tertiary care epilepsy center.
     Epilepsy Res. 2024;209:107479.
     PubMed     Abstract available
     
     
     
101. ASHTIANI SH, Akel S, Berger E, Zelano J, et al
     Plasma proteomics in epilepsy: Network-based identification of proteins associated with seizures.
     Epilepsy Res. 2024;209:107480.
     PubMed     Abstract available
     
     
     
102. HOWELL AM, Wang S, Ragheb J, Decker J, et al
     Validation of hemispherectomy outcome prediction scale in treatment of medically intractable epilepsy.
     Epilepsy Res. 2024;208:107477.
     PubMed     Abstract available
     
     
     
103. SAMOES R, Cavalheiro A, Santos C, Lopes J, et al
     MicroRNAs as potential biomarkers of response to modified Atkins diet in treatment of adults with drug-resistant epilepsy: A proof-of-concept study.
     Epilepsy Res. 2024;208:107478.
     PubMed     Abstract available
     
     
     
104. SHARMA D, Sarangi SC, Sinha S, Pattnaik SS, et al
     Effect of trans 4-butylcyclohexane carboxylic acid (4-BCCA) upon neurodegeneration, oxidative stress related to epileptogenesis in pilocarpine-induced status epilepticus.
     Epilepsy Res. 2024;209:107471.
     PubMed     Abstract available
     
     
     
105. JI X, Dang Y, Song M, Liu A, et al
     A universal method for seizure onset zone localization in focal epilepsy using standard deviation of spike amplitude.
     Epilepsy Res. 2024;208:107475.
     PubMed     Abstract available
     
     
     
106. LI CJ, Hou JC, Chou CC, Shih YC, et al
     Face swapping in seizure videos for patient deidentification.
     Epilepsy Res. 2024;207:107453.
     PubMed     Abstract available
     
     
     October 2024
107. JHA R, Chua MMJ, Liu DD, Richardson RM, et al
     Beyond seizure freedom: Reduction in anti-seizure medication after epilepsy surgery.
     Epilepsy Res. 2024;208:107473.
     PubMed     Abstract available
     
     
     
108. TSERIOTIS VS, Kimiskidis VK, Chlorogiannis DD, Arnaoutoglou M, et al
     Repetitive transcranial magnetic stimulation in murine models of epilepsy: A systematic review of methodological aspects and outcomes.
     Epilepsy Res. 2024;208:107468.
     PubMed     Abstract available
     
     
     
109. SUN Y, Tang X, Li Y, Gao C, et al
     Evaluating the efficacy of transcranial direct current stimulation for refractory epilepsy: A meta-analysis of RCTs and non-RCTs.
     Epilepsy Res. 2024;208:107456.
     PubMed     Abstract available
     
     
     
110. KAUR A, Kaur A, Samriti, Goel RK, et al
     Attenuation of mitochondrial refractory epilepsy in rotenone corneal kindling model of drug resistance by idebenone: An approach to bypass mitochondrial complex I.
     Epilepsy Res. 2024;207:107458.
     PubMed     Abstract available
     
     
     
111. VARNER JA, Rezaie R, Noorizadeh N, Boop FA, et al
     Transcranial magnetic stimulation and magnetoencephalography are feasible alternatives to invasive methods in optimizing responsive neurostimulation device placement.
     Epilepsy Res. 2024;206:107426.
     PubMed     Abstract available
     
     
     September 2024
112. SAITO T, Miyagawa N, Kanazawa K, Iwasaki M, et al
     Epidemiology and real-world management of childhood epilepsy in Japan: A descriptive study using a health claim database.
     Epilepsy Res. 2024;207:107455.
     PubMed     Abstract available
     
     
     
113. MATSUURA R, Hamano SI, Koichihara R, Takeda R, et al
     Serum matrix metallopeptidase-9 levels in infantile epileptic spasms syndrome of unknown etiology.
     Epilepsy Res. 2024;207:107454.
     PubMed     Abstract available
     
     
     
114. THAPA S, Panah MY, Vaheb S, Dahal K, et al
     Psychosis and schizophrenia among patients with epilepsy: A systematic review and meta-analysis.
     Epilepsy Res. 2024;207:107452.
     PubMed     Abstract available
     
     
     
115. SAFIYE Y, Gulcan BT, Zulfunaz O, Ersoy A, et al
     The relationship between perceived stress, spiritual well-being and alexithymia in people with epilepsy: A path analysis.
     Epilepsy Res. 2024;207:107450.
     PubMed     Abstract available
     
     
     
116. FERNANDES M, Cardall A, Moura LM, McGraw C, et al
     Extracting seizure control metrics from clinic notes of patients with epilepsy: A natural language processing approach.
     Epilepsy Res. 2024;207:107451.
     PubMed     Abstract available
     
     
     
117. SALLELES E, Samson S, Denos M, Mere M, et al
     Hippocampal activations obtained during language fMRI tasks: A complementary tool for predicting postoperative memory prognosis.
     Epilepsy Res. 2024;205:107405.
     PubMed     Abstract available
     
     
     
118. KAUSHIK M, Mahajan S, Machahary N, Thakran S, et al
     Predicting efficacy of antiseizure medication treatment with machine learning algorithms in North Indian population.
     Epilepsy Res. 2024;205:107404.
     PubMed     Abstract available
     
     
     
119. JHA R, Mj Chua M, Nawabi N, Cash SS, et al
     Foramen ovale electrode investigation in the era of SEEG: Results and a reappraisal.
     Epilepsy Res. 2024;205:107401.
     PubMed     Abstract available
     
     
     
120. NIZAMI FM, Trivedi S, Kalita J
     A systematic review of electroencephalographic findings in Lennox-Gastaut syndrome.
     Epilepsy Res. 2024;205:107406.
     PubMed     Abstract available
     
     
     August 2024
121. ADIGA S, Mundlamuri RC, Asranna A, Vishwanathan LG, et al
     New onset status epilepticus and its long-term outcome: A cohort study.
     Epilepsy Res. 2024;206:107442.
     PubMed     Abstract available
     
     
     
122. BONNO D, Vanatta L, Kossoff E
     A side-by-side comparison of fine-tuning options for treatment of medically refractory epilepsy: Antiseizure medications, vagus nerve stimulation and ketogenic diet therapies.
     Epilepsy Res. 2024;206:107441.
     PubMed     Abstract available
     
     
     
123. KAMITAKI BK, Maniar S, Rambhatla R, Gao K, et al
     Health insurance and transportation barriers impact access to epilepsy care in the United States.
     Epilepsy Res. 2024;205:107424.
     PubMed     Abstract available
     
     
     
124. SCHNEIDER BM, Krapf EM, Hassara KE, Stanford LD, et al
     Differential contributions of performance-based and parental reports of executive functioning on memory in pediatric focal and generalized epilepsies.
     Epilepsy Res. 2024;205:107423.
     PubMed     Abstract available
     
     
     
125. MOURA L, Karakis I, Howard D
     Emergency department utilization among adults with epilepsy: A multi-state cross-sectional analysis, 2010-2019.
     Epilepsy Res. 2024;205:107427.
     PubMed     Abstract available
     
     
     
126. VERMA A, Pathak P, Mishra AK, Upadhya S, et al
     Factors linked with perceived stigma amid people with Epilepsy -across sectional study.
     Epilepsy Res. 2024;205:107428.
     PubMed     Abstract available
     
     
     
127. MIECZNIKOWSKI KB, Leach J, Rozhkov L, Mangano FT, et al
     Impact of seizure onset zone and intracranial electroencephalography ictal characteristics on epilepsy surgery outcomes in tuberous sclerosis complex.
     Epilepsy Res. 2024;205:107422.
     PubMed     Abstract available
     
     
     
128. MARQUES P, Moloney PB, Ji C, Zulfiqar Ali Q, et al
     Do germline genetic variants influence surgical outcomes in drug-resistant epilepsy?
     Epilepsy Res. 2024;206:107425.
     PubMed     Abstract available
     
     
     
129. GOEL A, Seri S, Agrawal S, Kumar R, et al
     The utility of Multicentre Epilepsy Lesion Detection (MELD) algorithm in identifying epileptic activity and predicting seizure freedom in MRI lesion-negative paediatric patients.
     Epilepsy Res. 2024;206:107429.
     PubMed     Abstract available
     
     
     
130. MURALIDHARAN P, Sankaran R, Bendapudi P, Kumar CS, et al
     AI in ECG: Validating an ambulatory semiology labeller and predictor.
     Epilepsy Res. 2024;204:107403.
     PubMed     Abstract available
     
     
     July 2024
131. LIU R, Zhu G, Li D, Gao Y, et al
     Corrigendum to "An rs-fMRI based neuroimaging marker for adult absence epilepsy" [2024 204, 107400].
     Epilepsy Res. 2024 Jul 26:107420. doi: 10.1016/j.eplepsyres.2024.107420.
     PubMed    
     
     
     
132. SAHA L, Kumari P, Sinha VR, Gautam V, et al
     Role of berberine nanoformulation in epilepsy: A novel therapeutic strategy.
     Epilepsy Res. 2024;205:107419.
     PubMed     Abstract available
     
     
     
133. SUBRAMANIAM VR, Goldstein J, Mu L, Kwon CS, et al
     In-hospital outcomes in people with autism and epilepsy - A population-based study.
     Epilepsy Res. 2024;205:107417.
     PubMed     Abstract available
     
     
     
134. YIMENICIOGLU S, Ekici A
     Hot water epilepsy with alone and spontaneous seizures in childhood.
     Epilepsy Res. 2024;205:107418.
     PubMed     Abstract available
     
     
     
135. MOSINI AC, Sanabria V, Nakamura TKE, Calio ML, et al
     Posttraumatic epilepsy: Integrating clinical, inflammatory, and genetic profiles in traumatic brain injury patients.
     Epilepsy Res. 2024;205:107402.
     PubMed     Abstract available
     
     
     
136. SAMANTA D, Aungaroon G, Albert GW, Karakas C, et al
     Advancing thalamic neuromodulation in epilepsy: Bridging adult data to pediatric care.
     Epilepsy Res. 2024;205:107407.
     PubMed     Abstract available
     
     
     
137. YIN N, Han Y, Wang L, Yang F, et al
     Localization of epileptogenic zone based on time-varying effective networks.
     Epilepsy Res. 2024;205:107409.
     PubMed     Abstract available
     
     
     
138. WANG ZJ, Park S, Kim HD, Kang HC, et al
     Functional brain network analysis using electroencephalography in late-onset Lennox-Gastaut syndrome.
     Epilepsy Res. 2024;203:107370.
     PubMed     Abstract available
     
     
     June 2024
139. LIU R, Zhu G, Gao Y, Li D, et al
     An rs-fMRI based neuroimaging marker for adult absence epilepsy.
     Epilepsy Res. 2024;204:107400.
     PubMed     Abstract available
     
     
     
140. YU Y, Chen Z, Yang Y, Zhang J, et al
     Development and validation of an interpretable machine learning model for predicting post-stroke epilepsy.
     Epilepsy Res. 2024;205:107397.
     PubMed     Abstract available
     
     
     
141. GREGORY J, Cohen A, Cutler A, Craig A, et al
     Morbidity Associated with Deviation from Pediatric Status Epilepticus Guidelines.
     Epilepsy Res. 2024;204:107394.
     PubMed     Abstract available
     
     
     
142. MUNGER CLARY HM, Snively BM, Kumi-Ansu Y, Alexander HB, et al
     Quality of life during usual epilepsy care for anxiety or depression symptoms: Secondary patient-reported outcomes in a randomized trial of remote assessment methods.
     Epilepsy Res. 2024;204:107396.
     PubMed     Abstract available
     
     
     
143. RAY S, Nathan J, Godhia M
     Efficacy and tolerability of classical and polyunsaturated fatty acids ketogenic diet in controlling paediatric refractory epilepsy - A randomized study.
     Epilepsy Res. 2024;204:107395.
     PubMed     Abstract available
     
     
     
144. GEFFERIE SR, Ossenblok PPW, Dietze CS, Sargsyan A, et al
     Detection of short-lasting and ictal spike-and-wave discharges in around-the-ears EEG recordings in children with absence epilepsy.
     Epilepsy Res. 2024;204:107385.
     PubMed     Abstract available
     
     
     May 2024
145. DUREZ A, Theys T, van Loon J, Van Paesschen W, et al
     Retention rate of vagus nerve stimulation for the treatment of drug-resistant epilepsy: A single-centre, retrospective study.
     Epilepsy Res. 2024;203:107383.
     PubMed     Abstract available
     
     
     
146. POLET SS, de Koning TJ, Lambrechts RA, Tijssen MAJ, et al
     Conventional and novel anti-seizure medications reveal a particular role for GABA(A) in a North Sea progressive myoclonus Epilepsy Drosophila model.
     Epilepsy Res. 2024;203:107380.
     PubMed     Abstract available
     
     
     
147. MILLER KR, Barnard S, Juarez-Colunga E, French JA, et al
     Long-term seizure diary tracking habits in clinical studies: Evidence from the Human Epilepsy Project.
     Epilepsy Res. 2024;203:107379.
     PubMed     Abstract available
     
     
     
148. CHANRA V, Chudzinska A, Braniewska N, Silski B, et al
     Development and prospective clinical validation of a convolutional neural network for automated detection and segmentation of focal cortical dysplasias.
     Epilepsy Res. 2024;202:107357.
     PubMed     Abstract available
     
     
     
149. SCHOEMAKER R, Krauwinkel W, Elshoff JP, Stockis A, et al
     Brivaracetam exposure-response predictions in pediatric patients from age 1 month: Extrapolation of levetiracetam adult-pediatric scaling to brivaracetam.
     Epilepsy Res. 2024;202:107332.
     PubMed     Abstract available
     
     
     
150. YAO J, Liao C, Wang Y, Xiao Z, et al
     A meta-analysis of the relationship between abnormal pretreatment EEG and epilepsy recurrence.
     Epilepsy Res. 2024;203:107368.
     PubMed     Abstract available
     
     
     April 2024
151. ALASHJAIE R, Kerr EN, AlShoumer A, Hawkins C, et al
     Surgical outcomes in children with drug-resistant epilepsy and hippocampal sclerosis.
     Epilepsy Res. 2024;203:107367.
     PubMed     Abstract available
     
     
     
152. MARITAN BS, Favaretto G, Tarifa B, de Faria FM, et al
     Clinical and sociodemographic characteristics of patients with epilepsy attended at a regional reference psychiatric emergency unit.
     Epilepsy Res. 2024;203:107369.
     PubMed     Abstract available
     
     
     
153. PENA-CEBALLOS J, Moloney PB, Kilbride RD, Naggar HE, et al
     Oligoepilepsy and lifelong seizure susceptibility in epilepsy with generalized tonic-clonic seizures alone: Experience at an adult tertiary center.
     Epilepsy Res. 2024;202:107362.
     PubMed     Abstract available
     
     
     
154. FANG C, Yang L, Xiao F, Yan K, et al
     Genotype and phenotype features and prognostic factors of neonatal-onset pyridoxine-dependent epilepsy: A systematic review.
     Epilepsy Res. 2024;202:107363.
     PubMed     Abstract available
     
     
     
155. KITAURA H, Fukushima K, Fukuda M, Ito Y, et al
     Pharmacological evaluation of E2730, a novel selective uncompetitive GAT1 inhibitor, on epileptiform activities in resected brain tissues from human focal cortical dysplasia ex vivo.
     Epilepsy Res. 2024;202:107364.
     PubMed     Abstract available
     
     
     
156. GHEARING GR, Tyrrell M, Black J, Krehel-Montgomery J, et al
     Clinical correlates of negative health events and disparities among adults with epilepsy enrolled in a self-management clinical trial.
     Epilepsy Res. 2024;203:107366.
     PubMed     Abstract available
     
     
     
157. ALJAFEN BN, Alneseyan RA, Bahr MH, Muayqil TA, et al
     Current practice and safety measures in epilepsy monitoring units in the Gulf Cooperation Council Countries: A cross-sectional study.
     Epilepsy Res. 2024;202:107361.
     PubMed     Abstract available
     
     
     
158. SHIBATA T, Tsuchiya H, Akiyama M, Akiyama T, et al
     Modulation index predicts the effect of ethosuximide on developmental and epileptic encephalopathy with spike-and-wave activation in sleep.
     Epilepsy Res. 2024;202:107359.
     PubMed     Abstract available
     
     
     
159. SINGH AP, Chaudhary V, Kumari S, Dhir D, et al
     Nonadherence to antiepileptic medication and associated factors among persons with epilepsy in India: A systematic review and meta-analysis.
     Epilepsy Res. 2024;202:107358.
     PubMed     Abstract available
     
     
     March 2024
160. ZHAO K, Li Y, Lai H, Niu R, et al
     Alterations in HCN1 expression and distribution during epileptogenesis in rats.
     Epilepsy Res. 2024;202:107355.
     PubMed     Abstract available
     
     
     
161. CARABALLO RH, Gallo A, Reyes G, Flores G, et al
     Epileptic spasms in clusters with hypsarrhythmia in infancy and childhood: A single age-dependent type of epilepsy or well-defined epileptic syndrome?
     Epilepsy Res. 2024;202:107354.
     PubMed     Abstract available
     
     
     
162. SULLIVAN J, Gunning B, Zafar M, Guerrini R, et al
     Corrigendum to "Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy" [Epilepsy Res. (2023) 191 107112].
     Epilepsy Res. 2024 Mar 12:107342. doi: 10.1016/j.eplepsyres.2024.107342.
     PubMed    
     
     
     
163. PRANDIN G, Furlanis G, Scali I, Palacino F, et al
     Status Epilepticus after mechanical thrombectomy: The role of early EEG assessment in Stroke Unit, clinical and radiological prognostication.
     Epilepsy Res. 2024;202:107343.
     PubMed     Abstract available
     
     
     
164. FASALUDEEN A, McTague A, Jose M, Banerjee M, et al
     Genetic variant interpretation for the neurologist - A pragmatic approach in the next-generation sequencing era in childhood epilepsy.
     Epilepsy Res. 2024;201:107341.
     PubMed     Abstract available
     
     
     
165. LI Q, Qu Z, Jia L, Wang W, et al
     Expression and correlation of the NOD-like receptor family, pyrin domain-containing 3 inflammasome and the silent information regulator 1 in patients with drug-resistant epilepsy.
     Epilepsy Res. 2024;201:107338.
     PubMed     Abstract available
     
     
     
166. FOX J, Bollig MK, Mishra M, Jacobs M, et al
     Neuropsychological characteristics of drug resistant epilepsy patients with and without comorbid functional seizures.
     Epilepsy Res. 2024;201:107340.
     PubMed     Abstract available
     
     
     
167. HEBERT J, De Santis RJ, Daniyal L, Mannan S, et al
     Epilepsy in neurofibromatosis type 1: Prevalence, phenotype, and genotype in adults.
     Epilepsy Res. 2024;202:107336.
     PubMed     Abstract available
     
     
     
168. FRINGUELLO AR, Colbourn R, Goodman JH, Michelson HB, et al
     Rapid volume pulsations of the extracellular space accompany epileptiform activity in trauma-injured neocortex and depend on the sodium-bicarbonate cotransporter NBCe1.
     Epilepsy Res. 2024;201:107337.
     PubMed     Abstract available
     
     
     
169. DELANTY N, Mohanraj R, Shankar R, Wehner T, et al
     Perampanel for the treatment of epilepsy with genetic aetiology: Real-world evidence from the PERMIT Extension study.
     Epilepsy Res. 2024;202:107339.
     PubMed     Abstract available
     
     
     
170. KAN-TOR Y, Ness L, Szlak L, Benninger F, et al
     Comparing the efficacy of anti-seizure medications using matched cohorts on a large insurance claims database.
     Epilepsy Res. 2024;201:107313.
     PubMed     Abstract available
     
     
     
171. YILMAZ EROL T, Ilgezdi Kaya I, Ur Ozcelik E, Aksu S, et al
     Acute effect of transcranial direct current stimulation on photoparoxysmal response.
     Epilepsy Res. 2024;201:107320.
     PubMed     Abstract available
     
     
     
172. CHENG Y, Zhang Y, Huang P, Cheng Q, et al
     Luteolin ameliorates pentetrazole-induced seizures through the inhibition of the TLR4/NF-kappaB signaling pathway.
     Epilepsy Res. 2024;201:107321.
     PubMed     Abstract available
     
     
     February 2024
173. REN Z, Wang B, Yue M, Han J, et al
     Construction of machine learning models for recognizing comorbid anxiety in epilepsy patients based on their clinical and quantitative EEG features.
     Epilepsy Res. 2024;201:107333.
     PubMed     Abstract available
     
     
     
174. OMISADE A, Nugent M, O'Grady C, Ikeda K, et al
     Cognitive dysfunction at epilepsy onset as a marker for seizure recurrence.
     Epilepsy Res. 2024;202:107335.
     PubMed     Abstract available
     
     
     
175. KOMAL K, Cleary F, Wells JSG, Bennett L, et al
     A systematic review of the literature reporting on remote monitoring epileptic seizure detection devices.
     Epilepsy Res. 2024;201:107334.
     PubMed     Abstract available
     
     
     
176. SAFEER V S M, Gupta P, Behl S, Bansal D, et al
     Mobile health applications for epilepsy in Indian app stores: A systematic review and content analysis using the mobile app rating scale.
     Epilepsy Res. 2024;201:107331.
     PubMed     Abstract available
     
     
     
177. PANDA PK, Chakrabarty B, Jauhari P, Sharawat IK, et al
     Efficacy of daily versus intermittent low glycemic index therapy diet in children with drug-resistant epilepsy: A randomized controlled trial.
     Epilepsy Res. 2024;201:107322.
     PubMed     Abstract available
     
     
     
178. YARAKI PT, Yu YJ, AlKhateeb M, Mirsattari SM, et al
     Longitudinal Comparison of PNES spell and ASM reduction in PNES Patients with and without Epilepsy Discharged from an Epilepsy Monitoring Unit.
     Epilepsy Res. 2024;201:107319.
     PubMed     Abstract available
     
     
     
179. REED L, Ciliberto M, Fong SL, Nickels K, et al
     Efficacy of felbamate in a cohort of patients with epilepsy with myoclonic atonic seizures (EMAtS).
     Epilepsy Res. 2024;201:107314.
     PubMed     Abstract available
     
     
     
180. VAJDA FJE, O'Brien TJ, Graham JE, Hitchcock AA, et al
     The teratogenesis risk associated with antiseizure medication duotherapy in women with epilepsy.
     Epilepsy Res. 2024;200:107316.
     PubMed     Abstract available
     
     
     
181. ZHAO T, Zhang X, Cui X, Chen Y, et al
     Awareness, attitudes and first aid knowledge of epilepsy among university students - A cross-sectional study in Henan Province, China.
     Epilepsy Res. 2024;201:107315.
     PubMed     Abstract available
     
     
     
182. ZAFRA-PUERTA L, Colpaert M, Iglesias-Cabeza N, Burgos DF, et al
     Effect of intracerebroventricular administration of alglucosidase alfa in two mouse models of Lafora disease: Relevance for clinical practice.
     Epilepsy Res. 2024;200:107317.
     PubMed     Abstract available
     
     
     
183. ABOUMATAR S, Ferrari L, Stern S, Wade CT, et al
     Reductions in concomitant antiseizure medication drug load during adjunctive cenobamate therapy: Post-hoc analysis of a subset of patients from a phase 3, multicenter, open-label study.
     Epilepsy Res. 2024;200:107306.
     PubMed     Abstract available
     
     
     
184. BANO A, Garg A, Mumtaz, Nidhi, et al
     The anti-seizure potential of cysteine leukotriene receptor antagonists: A systematic review of animal studies.
     Epilepsy Res. 2024;200:107305.
     PubMed     Abstract available
     
     
     
185. PARK KM, Park S, Hur YJ
     Brain network reconstruction of abnormal functional connectivity in Lennox-Gastaut syndrome according to drug responsiveness: A retrospective study.
     Epilepsy Res. 2024;200:107312.
     PubMed     Abstract available
     
     
     
186. BARNES JP, Dial H, Owens W, DeClercq J, et al
     Adherence and discontinuation of prescription cannabidiol for the management of seizure disorders at an integrated care center.
     Epilepsy Res. 2024;200:107300.
     PubMed     Abstract available
     
     
     
187. SALDARIS JM, Jacoby P, Marsh ED, Suter B, et al
     Adapting a measure of gross motor skills for individuals with CDKL5 deficiency disorder: A psychometric study.
     Epilepsy Res. 2024;200:107287.
     PubMed     Abstract available
     
     
     
188. FITZGERALD PJ
     Neural hyperexcitability in Angelman syndrome: Genetic factors and pharmacologic treatment approaches.
     Epilepsy Res. 2024;200:107286.
     PubMed     Abstract available
     
     
     
189. BERG AT, Dixon-Salazar T, Meskis MA, Danese SR, et al
     Caregiver-reported outcomes with real-world use of cannabidiol in Lennox-Gastaut syndrome and Dravet syndrome from the BECOME survey.
     Epilepsy Res. 2024;200:107280.
     PubMed     Abstract available
     
     
     January 2024
190. ACAR A, Zampino A, Fotedar N
     EEG based oculographic analysis of epileptic nystagmus.
     Epilepsy Res. 2024;200:107311.
     PubMed     Abstract available
     
     
     
191. SALIM O, Chari A, Ben Zvi I, Batchelor R, et al
     Patient, parent and carer perspectives surrounding expedited paediatric epilepsy surgery.
     Epilepsy Res. 2024;200:107309.
     PubMed     Abstract available
     
     
     
192. REIJNEVELD JC, Thijs RD, van Thuijl HF, Appelhof BA, et al
     Clinical outcome assessment in patients with epilepsy: The value of health-related quality of life measurements.
     Epilepsy Res. 2024;200:107310.
     PubMed     Abstract available
     
     
     
193. COLIN J, Rossetti AO, Daniel RT, Bartoli A, et al
     The impact of a history of status epilepticus for epilepsy surgery outcome.
     Epilepsy Res. 2024;200:107308.
     PubMed     Abstract available
     
     
     
194. ARAI Y, Inaji M, Shimizu K, Kondo S, et al
     Long-term efficacy and safety of perampanel as an add-on therapy in patients with epilepsy.
     Epilepsy Res. 2024;200:107307.
     PubMed     Abstract available
     
     
     
195. ZHOU Q, Zhang N, Wang M, Zhao Q, et al
     Adenosine kinase gene modified mesenchymal stem cell transplantation retards seizure severity and associated cognitive impairment in a temporal lobe epilepsy rat model.
     Epilepsy Res. 2024;200:107303.
     PubMed     Abstract available
     
     
     
196. KYYRIAINEN J, Andrade P, Ekolle Ndode-Ekane X, Manninen E, et al
     Brain abscess - A rare confounding factor for diagnosis of post-traumatic epilepsy after lateral fluid-percussion injury.
     Epilepsy Res. 2024;200:107301.
     PubMed     Abstract available
     
     
     
197. LEVI-ABAYO S, Ben-Shabat S, Gandelman-Marton R
     Guidelines and epilepsy practice: Antiseizure medication initiation following an unprovoked first seizure in adults.
     Epilepsy Res. 2024;200:107304.
     PubMed     Abstract available
     
     
     
198. MULLER S, Kartheus M, Hendinger E, Hubner DC, et al
     Persistent Kv7.2/7.3 downregulation in the rat pilocarpine model of mesial temporal lobe epilepsy.
     Epilepsy Res. 2024;200:107296.
     PubMed     Abstract available
     
     
     
199. RAN L, Xu M, Zhang Z, Zeng X, et al
     The association of nutrient intake with epilepsy: A cross-sectional study from NHANES, 2013-2014.
     Epilepsy Res. 2024;200:107297.
     PubMed     Abstract available
     
     
     
200. XIONG W, Yang X, Lu L, Ma X, et al
     Quality indicators for epilepsy management in China: The development of a tool to assess care and first three-year report.
     Epilepsy Res. 2024;200:107295.
     PubMed     Abstract available
     
     
     
201. COOPER MS, Mackay MT, Shepherd DA, Dagia C, et al
     Distinct manifestations and potential mechanisms of seizures due to cortical versus white matter injury in children.
     Epilepsy Res. 2024;199:107267.
     PubMed     Abstract available
     
     
     
202. BUCCOLIERO AM, Caporalini C, Moscardi S, Cetica V, et al
     Leat-associated seizures the possible role of EAAT2, pyruvate carboxylase and glutamine synthetase.
     Epilepsy Res. 2024;199:107258.
     PubMed     Abstract available
     
     
     
203. SIMEONE KA, Martenz DM, Iyer SH, Booth CP, et al
     Personalization of SUDEP risk: A survey of transient subclinical comorbid changes.
     Epilepsy Res. 2024;199:107259.
     PubMed     Abstract available
     
     
     
204. SIERRA-MARCOS A, Ribosa-Nogue R, Vidal-Robau N, Aldecoa I, et al
     Inherited SCN1A missense mutation in a Dravet Syndrome family: Neuropathological correlation, family screening and implications for adult carriers.
     Epilepsy Res. 2024;199:107266.
     PubMed     Abstract available
     
     
     December 2023
205. WANG Z, Zhang X, Meiduo G, Song M, et al
     Time-effectiveness of low-frequency rTMS for epilepsy and improvement in cognitive function in patients: A systematic review and meta-analysis.
     Epilepsy Res. 2023;199:107277.
     PubMed     Abstract available
     
     
     
206. BHARTI SK, Gupta I, Akshima, Madaan P, et al
     Societal costs of illness for infantile epileptic spasms syndrome and evolutionary cost prediction in the era of WHO's IGAP.
     Epilepsy Res. 2023;199:107284.
     PubMed     Abstract available
     
     
     
207. ILYAS M, Tariq F, Ishaq R, Habiba U, et al
     Whole exome sequencing identifies variable expressivity of CLN6 variants in Progressive myoclonic epilepsy affected families.
     Epilepsy Res. 2023;201:107283.
     PubMed     Abstract available
     
     
     
208. FREIMAN S, Hauser WA, Rider F, Gulyaeva N, et al
     Post-stroke epilepsy: From clinical predictors to possible mechanisms.
     Epilepsy Res. 2023;199:107282.
     PubMed     Abstract available
     
     
     
209. LETEN HM, Karterud HN, Mengshoel AM
     Individuals' invisible work continues after epilepsy surgery: A qualitative interview study.
     Epilepsy Res. 2023;199:107281.
     PubMed     Abstract available
     
     
     
210. MBIZVO GK, Simpson CR, Duncan SE, Chin RFM, et al
     Critical success index or F measure to validate the accuracy of administrative healthcare data identifying epilepsy in deceased adults in Scotland.
     Epilepsy Res. 2023;199:107275.
     PubMed     Abstract available
     
     
     
211. ALKHALDI NA, Paredes-Aragon E, Kim DD, Yu YJ, et al
     Psychogenic non-epileptic seizures with and without epilepsy: Exploring the influence of co-existing psychiatric disorders on clinical characteristics and outcomes.
     Epilepsy Res. 2023;199:107279.
     PubMed     Abstract available
     
     
     
212. CHAPMAN KE, Haubenberger D, Jen E, Tishchenko A, et al
     Unmet needs in epileptic encephalopathy with spike-and-wave activation in sleep: A systematic review.
     Epilepsy Res. 2023;199:107278.
     PubMed     Abstract available
     
     
     November 2023
213. ROSHAN JHN, Chamanabad AG, Mashhadi A, Motamedi M, et al
     Cathodal HD-tDCS and attention: A study on patients with intractable left lateral frontal lobe epilepsy.
     Epilepsy Res. 2023;199:107265.
     PubMed     Abstract available
     
     
     
214. BORDES A, El Bendary Y, Goudard G, Masson V, et al
     Benefits of vagus nerve stimulation on psychomotor functions in patients with severe drug-resistant epilepsy.
     Epilepsy Res. 2023;198:107260.
     PubMed     Abstract available
     
     
     
215. NDODE-EKANE XE, Ali I, Santana-Gomez CE, Casillas-Espinosa PM, et al
     Successful harmonization in EpiBioS4Rx biomarker study on post-traumatic epilepsy paves the way towards powered preclinical multicenter studies.
     Epilepsy Res. 2023;199:107263.
     PubMed     Abstract available
     
     
     
216. RIZZI M, Nichelatti M, Ferri L, Consales A, et al
     Seizure outcomes and safety profiles of surgical options for epilepsy associated to hypothalamic hamartomas. A systematic review and meta-analysis.
     Epilepsy Res. 2023;198:107261.
     PubMed     Abstract available
     
     
     
217. SHAO M, Yu H, Santhakumar V, Yu J, et al
     Antiepileptogenic and neuroprotective effect of mefloquine after experimental status epilepticus.
     Epilepsy Res. 2023;198:107257.
     PubMed     Abstract available
     
     
     
218. MATTHEWS EA, Harward S, Marek J, Drysdale ND, et al
     A simple, automated method of seizure detection in mouse models of temporal lobe epilepsy.
     Epilepsy Res. 2023;198:107256.
     PubMed     Abstract available
     
     
     
219. AKEL S, Banote RK, Asztely F, Zelano J, et al
     Protein profiling in plasma for biomarkers of seizure.
     Epilepsy Res. 2023;197:107241.
     PubMed     Abstract available
     
     
     
220. COUSYN L, Dono F, Navarro V, Chavez M, et al
     Can heart rate variability identify a high-risk state of upcoming seizure?
     Epilepsy Res. 2023;197:107232.
     PubMed     Abstract available
     
     
     
221. ZINIEL SI, Mackie A, Saldaris J, Leonard H, et al
     The development, content and response process validation of a caregiver-reported severity measure for CDKL5 deficiency disorder.
     Epilepsy Res. 2023;197:107231.
     PubMed     Abstract available
     
     
     October 2023
222. KAUR A, Kumar S, Goel RK
     Adjunct antiseizure effect of clotrimazole in a rotenone corneal kindling mouse model of mitochondrial drug-resistant epilepsy.
     Epilepsy Res. 2023;198:107246.
     PubMed     Abstract available
     
     
     
223. PENG W, Lu L, Wang P, Zhou Y, et al
     The initial treatment in convulsive status epilepticus in China: A multi-center observational study.
     Epilepsy Res. 2023;197:107245.
     PubMed     Abstract available
     
     
     
224. MA Y, Deng J, Fu Z, Chen C, et al
     Efficacy and tolerability of oxcarbazepine in the treatment of focal epilepsy in neonates and infants under 3 months of age: A single-center retrospective analysis.
     Epilepsy Res. 2023;197:107240.
     PubMed     Abstract available
     
     
     
225. LIU Q, Tan B, Zhang J, Jin Y, et al
     Premature mortality risk in individuals with convulsive epilepsy: Results from a longitudinal, prospective, population-based study.
     Epilepsy Res. 2023;197:107243.
     PubMed     Abstract available
     
     
     
226. BIJLENGA D, Fronczek R, Gorter EJ, Thijs RD, et al
     Vigilance and circadian function in daytime and nocturnal epilepsy compared to controls.
     Epilepsy Res. 2023;197:107238.
     PubMed     Abstract available
     
     
     
227. AREVALO-ASTRADA MA, Suller-Marti A, McLachlan RS, Paredes-Aragon E, et al
     Involvement of the posterior cingulate gyrus in temporal lobe epilepsy: A study using stereo-EEG.
     Epilepsy Res. 2023;198:107237.
     PubMed     Abstract available
     
     
     
228. MANJUNATHA RT, Vakilna YS, Chaitanya G, Alamoudi O, et al
     Advancing the frontiers of thalamic neuromodulation: A review of emerging targets and paradigms.
     Epilepsy Res. 2023;196:107219.
     PubMed     Abstract available
     
     
     
229. POYTAKANGAS T, Saarinen JT, Basnyat P, Rainesalo S, et al
     Indications for the use of intravenous second-line antiseizure medications in an emergency room setting.
     Epilepsy Res. 2023;196:107218.
     PubMed     Abstract available
     
     
     
230. TANI H, Tateishi Y, Kobayashi Y, Ishikawa N, et al
     HFA analysis using scalp electroencephalograms in two cases of Rasmussen's syndrome.
     Epilepsy Res. 2023;196:107205.
     PubMed     Abstract available
     
     
     
231. CHITOLINA R, Gallas-Lopes M, Reis CG, Benvenutti R, et al
     Chemically-induced epileptic seizures in zebrafish: A systematic review.
     Epilepsy Res. 2023;197:107236.
     PubMed     Abstract available
     
     
     September 2023
232. WIDMANN M, Lieb A, Mutti A, Schwarzer C, et al
     Dimethyl sulfoxide's impact on epileptiform activity in a mouse model of chronic temporal lobe epilepsy.
     Epilepsy Res. 2023;197:107235.
     PubMed     Abstract available
     
     
     
233. BEHESHTI S, Ershadi S, Zamani F, Azimzadeh M, et al
     Differential impact of a ghrelin receptor antagonist or inverse agonist in the electrical kindling model of epilepsy.
     Epilepsy Res. 2023;197:107234.
     PubMed     Abstract available
     
     
     
234. PAGANIN R, Paglioli E, Friedrich B, Alves Martins W, et al
     Resting-state fMRI in patients with refractory epilepsy with and without drop attacks: exploring the connectivity of sensorimotor cortex.
     Epilepsy Res. 2023;197:107233.
     PubMed     Abstract available
     
     
     
235. ALLEBONE J, Kanaan RA, Rayner G, Maller J, et al
     Neuropsychological function in psychosis of epilepsy.
     Epilepsy Res. 2023;196:107222.
     PubMed     Abstract available
     
     
     
236. ADDONA C, Hurlimann T, Jaitovich-Groisman I, Godard B, et al
     Experiences of adults living with refractory epilepsy and their views and expectations on receiving results from whole genome sequencing.
     Epilepsy Res. 2023;196:107221.
     PubMed     Abstract available
     
     
     
237. BUYUKBAYRAM Z, Aksoy M, Yilmaz R
     The effects of concealment of epilepsy on medication adherence in people with epilepsy: A cross-sectional study.
     Epilepsy Res. 2023;196:107220.
     PubMed     Abstract available
     
     
     August 2023
238. STERN S, Weingarten M, Mandapati S, Ferrari L, et al
     Real-world analysis of retention on cenobamate in patients with epilepsy in the United States.
     Epilepsy Res. 2023;197:107207.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Epilepsy is free of charge.